在诊断活检期间确定葡萄糖二烯治疗乳腺癌潜力的个体化治疗新技术

Cell & cellular life sciences journal Pub Date : 2023-01-01 DOI:10.23880/cclsj-16000186

Maher Monir Akl

{"title":"在诊断活检期间确定葡萄糖二烯治疗乳腺癌潜力的个体化治疗新技术","authors":"Maher Monir Akl","doi":"10.23880/cclsj-16000186","DOIUrl":null,"url":null,"abstract":"Breast cancer remains a significant challenge in the field of oncology, particularly the aggressive triple-negative breast cancer (TNBC) subtype, accounting for 15-20% of cases. TNBC lacks estrogen, progesterone, and HER2 receptors, making it difficult to target with conventional therapies. In light of this, there is an urgent need to explore novel treatment approaches that can effectively address the unique characteristics of TNBC","PeriodicalId":479978,"journal":{"name":"Cell & cellular life sciences journal","volume":"66 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Novel Technique for Individualized Treatment of Breast Cancer during Diagnostic Biopsy to Determine its Potential for Treatment with Glucosodiene\",\"authors\":\"Maher Monir Akl\",\"doi\":\"10.23880/cclsj-16000186\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Breast cancer remains a significant challenge in the field of oncology, particularly the aggressive triple-negative breast cancer (TNBC) subtype, accounting for 15-20% of cases. TNBC lacks estrogen, progesterone, and HER2 receptors, making it difficult to target with conventional therapies. In light of this, there is an urgent need to explore novel treatment approaches that can effectively address the unique characteristics of TNBC\",\"PeriodicalId\":479978,\"journal\":{\"name\":\"Cell & cellular life sciences journal\",\"volume\":\"66 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cell & cellular life sciences journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23880/cclsj-16000186\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell & cellular life sciences journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/cclsj-16000186","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

乳腺癌仍然是肿瘤学领域的一个重大挑战，特别是侵袭性三阴性乳腺癌(TNBC)亚型，占病例的15-20%。TNBC缺乏雌激素、孕激素和HER2受体，这使得常规治疗难以靶向。鉴于此，迫切需要探索能够有效解决TNBC独特特征的新型治疗方法

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

A Novel Technique for Individualized Treatment of Breast Cancer during Diagnostic Biopsy to Determine its Potential for Treatment with Glucosodiene

Breast cancer remains a significant challenge in the field of oncology, particularly the aggressive triple-negative breast cancer (TNBC) subtype, accounting for 15-20% of cases. TNBC lacks estrogen, progesterone, and HER2 receptors, making it difficult to target with conventional therapies. In light of this, there is an urgent need to explore novel treatment approaches that can effectively address the unique characteristics of TNBC

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cell & cellular life sciences journal

自引率

0.00%

发文量